Literature DB >> 21711313

Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine.

N J Kannegieter1, A Frogley, E Crispe, P D Kirkland.   

Abstract

As part of the control measures of the equine influenza (EI) outbreak, in addition to the strategic use of vaccination to provide buffer zones around infected populations, approval was obtained to vaccinate Thoroughbred racing horses. We review the clinical expression of the disease and virus excretion in a population of racehorses that were exposed to EI approximately 7 days after administration of a single dose of the canarypox-vectored recombinant compared with a similar unvaccinated population of horses at a nearby racetrack. Although this study was undertaken opportunistically and under the difficult field conditions that prevailed during the outbreak, our observations demonstrate that an appropriate vaccine can be effectively used as a disease control measure, even in the face of an outbreak, and therefore should be rapidly implemented as soon as there is evidence of infection in a naïve population.
© 2011 The Authors. Australian Veterinary Journal © 2011 Australian Veterinary Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711313     DOI: 10.1111/j.1751-0813.2011.00768.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  6 in total

1.  Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Authors:  Alida Ault; Alyse M Zajac; Wing-Pui Kong; J Patrick Gorres; Michael Royals; Chih-Jen Wei; Saran Bao; Zhi-yong Yang; Stephanie E Reedy; Tracy L Sturgill; Allen E Page; Jennifer Donofrio-Newman; Amanda A Adams; Udeni B R Balasuriya; David W Horohov; Thomas M Chambers; Gary J Nabel; Srinivas S Rao
Journal:  Vaccine       Date:  2012-03-23       Impact factor: 3.641

2.  Using a computer simulation model to examine the impact of biosecurity measures during a facility-level outbreak of equine influenza.

Authors:  Kelsey L Spence; Terri L O'Sullivan; Zvonimir Poljak; Amy L Greer
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

3.  Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims.

Authors:  Romain Paillot; Christel Marcillaud Pitel; Xavier D'Ablon; Stéphane Pronost
Journal:  Vaccines (Basel)       Date:  2017-12-04

4.  Assessment of Humoral and Long-Term Cell-Mediated Immune Responses to Recombinant Canarypox-Vectored Equine Influenza Virus Vaccination in Horses Using Conventional and Accelerated Regimens Respectively.

Authors:  Charles El-Hage; Carol Hartley; Catherine Savage; James Watson; James Gilkerson; Romain Paillot
Journal:  Vaccines (Basel)       Date:  2022-05-26

Review 5.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

Review 6.  The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary.

Authors:  Romain Paillot; Charles M El-Hage
Journal:  Pathogens       Date:  2016-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.